Molecular Testing Labs
Molecular Testing Labs is a CLIA-certified, CAP-accredited clinical diagnostic laboratory operating in Vancouver, WA and Irving, TX that enables at-home self-collection specimen testing across STI, hormone, pharmacogenetics, toxicology, and wellness panels, serving healthcare providers, health plans, digital health platforms, public health agencies, and clinical trial sponsors via a web portal and REST API.
- Company typePrivate
- Founded2011
- HeadquartersVancouver, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Molecular Testing Labs does
Molecular Testing Labs (operating as CareNexa, LLC dba Molecular Testing Labs) is a privately held clinical diagnostic laboratory founded in 2011 and headquartered in Vancouver, WA, with a secondary laboratory in Irving, TX. The company is CLIA-certified (high-complexity testing) and CAP-accredited at both locations, and operates an FDA-cleared self-collection diagnostic (the simpli-COLLECT STI Test). MTL's core capability is enabling at-home and alternative-site specimen collection through dried blood spot cards, oral swabs, urine samples, and multi-site STI kits, combined with vertical integration into kit construction and nationwide distribution via USPS and FedEx. The laboratory processes hundreds of thousands of tests per month across an assay menu spanning STI/sexual health, hormone panels, toxicology/drug screening, pharmacogenetics, methylation and fitness/nutrition genetics, UTI PCR, GLP-1 weight management monitoring, and colorectal cancer screening (FIT).
MTL serves five primary customer segments: healthcare providers (clinics, physicians, telehealth), health plans (population health and HEDIS/Star/MIPS gap closure), digital health and retail health platforms (white-label and API-embedded integrations), public health organizations (epidemiological screening programs), and clinical studies/trials. It goes to market through three motions: direct enterprise sales to providers and health plans, channel partnerships with digital health companies, and an API-first integration model supported by a comprehensive REST API with webhook notifications and a web-based Laboratory Information System portal (the Molecular Portal). Patient-facing kit registration and results delivery operate through a separate self-serve portal, and the company markets a consumer-facing wellness sub-brand called CareNexa Wellness.
MTL generates revenue through laboratory diagnostic testing services billed to Medicare, Medicaid, commercial insurance, workers' compensation, and self-pay patients; recurring subscription-style access fees for the LIS portal; and managed-services contracts for population health and gaps-in-care programs. The legal entity structure includes CareNexa, LLC and Blackfly Investments, LLC, both operating under the Molecular Testing Labs trade name in Washington state. No venture capital, private equity, or institutional investor ownership has been disclosed in the available materials, and the company is not publicly traded.
Molecular Testing Labs firmographics
Firmographics- Name
- Molecular Testing Labs
- Legal name
- Blackfly Investments, LLC, dba Molecular Testing Labs
- Website
- https://moleculartestinglabs.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Molecular Testing Labs is a CLIA-certified, CAP-accredited clinical diagnostic laboratory operating in Vancouver, WA and Irving, TX that enables at-home self-collection specimen testing across STI, hormone, pharmacogenetics, toxicology, and wellness panels, serving healthcare providers, health plans, digital health platforms, public health agencies, and clinical trial sponsors via a web portal and REST API.
- Ownership category
- akta.pro rank
Molecular Testing Labs industry classification
Industry- Product category
- Clinical Diagnostic Laboratory Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)
- akta.pro secondary industries
- Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE), Clinical Research & Trial Central Laboratories (HLAFAMAL)
Keywords
Where Molecular Testing Labs is headquartered
LocationHeadquarters
- HQ city
- Vancouver
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Molecular Testing Labs business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Laboratory Diagnostic Testing Services: Core revenue from processing clinical diagnostic tests for healthcare providers, health plans, and patients. Tests are billed to Medicare, Medicaid, commercial insurance, workers' compensation, or self-pay patients. The company offers comprehensive assay menu including STI testing, hormone panels, toxicology, pharmacogenetics, and wellness testing.
- Healthcare Operations and Portal Services: Provides web-based Laboratory Information System (LIS) portal access to healthcare professionals for test ordering and results retrieval, with associated service fees.
- Population Health and Gaps in Care Programs: Contracts with health plans to close care gaps through diagnostic testing, including HEDIS, Star, and MIPS measure support. May include claims-based reimbursement for testing services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Pay-as-you-go | Insurance-based laboratory testing |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels4 records
Molecular Testing Labs product offering
Product offeringCore offering
Molecular Testing Labs operates a CLIA-certified, CAP-accredited clinical diagnostic laboratory providing at-home specimen collection kits and molecular diagnostic testing for healthcare providers, health plans, digital health companies, public health organizations, and clinical study sponsors. The company offers a comprehensive test menu including STI screening, hormone panels, toxicology, pharmacogenetics, GLP-1 monitoring, wellness testing, and dried blood spot testing, supported by in-house kit construction, laboratory processing, and results delivery through a web-based LIS portal and a REST API.
Product overview
Molecular Testing Labs operates as a diagnostic laboratory offering a unified platform of specimen collection, testing, and results delivery services. The core offering consists of the Molecular Portal (LIS) and Molecular API, which together enable healthcare providers and partners to order tests, manage kits, and retrieve results. The product portfolio includes FDA-cleared simpli-COLLECT STI self-collection kits, dried blood spot testing, and specialized panels for GLP-1 weight management, drug screening, UTI, hormones, pharmacogenetics, and wellness (via CareNexa Wellness brand). Testing is processed through CLIA-certified and CAP-accredited laboratories with in-house logistics and fulfillment capabilities.
Differentiator
Problem solved
Functional benefit
Brands
- CareNexa Wellness: Wellness testing brand offering fitness and nutrition genetic testing panels including 34 gene targets for fitness and nutrition and 16 gene targets for methylation.
Products and services
- Molecular Portal (LIS Portal) Web-based Laboratory Information System portal enabling healthcare providers to place test orders, track kit status, and retrieve patient results through a secure online interface.
- Molecular API RESTful API enabling programmatic access to lab ordering, kit management, patient data retrieval, and webhook-based result notifications for integration with partner systems.
- simpli-COLLECT STI Test FDA-cleared self-collection test kit for STI screening enabling patients to collect specimens at home from oral, genital, and rectal sites for chlamydia, gonorrhea, and other sexually transmitted infections.
- Dried Blood Spot Testing Self-collection diagnostic testing using finger-prick blood samples collected on specialized dried blood spot cards, enabling at-home specimen collection with ambient-temperature shipping.
- GLP-1 Weight Management Testing Diagnostic panel monitoring glycemic control, lipid levels, thyroid function, and renal efficiency for patients on GLP-1 weight loss medications, with recommended testing every three months.
- Drug Testing and Screening Comprehensive toxicology services including oral fluid drug confirmations for substances such as amphetamines, benzodiazepines, opioids, and other drugs, supporting substance abuse detection and treatment monitoring.
- UTI PCR Testing Polymerase chain reaction testing for urinary tract infection pathogens including bacterial and fungal targets, with antibiotic resistance gene detection capabilities.
- Hormone Testing Comprehensive hormone panel including AMH, estradiol, progesterone, DHEA-S, testosterone, LH, FSH, TSH, free T4, and TPO antibodies for assessment of reproductive and thyroid health.
- Methylation and Fitness + Nutrition Testing Genetic testing panels analyzing 34 fitness and nutrition gene targets and 16 methylation pathway genes to provide personalized recommendations for diet, exercise, and health optimization.
- CareNexa Wellness Consumer-facing wellness sub-brand offering direct-to-patient health and wellness testing including thyroid panels, fitness nutrition genetic testing, and methylation analysis.
- Pharmacogenetics Testing Genetic testing panels covering addiction risk, cardiovascular disease, prenatal screening, ADHD, mental health risk, pain management, and PTSD risk through analysis of relevant gene variants.
- STI & Sexual Health Testing Comprehensive sexually transmitted infection screening including HIV, hepatitis B and C, chlamydia, gonorrhea, Mycoplasma genitalium, HPV, syphilis, RPR, and trichomonas testing with multi-site collection options.
- Cancer Screening (FIT) Fecal immunochemical test (FIT) for colorectal cancer screening providing non-invasive early detection.
- Kit Registration Portal Patient-facing web portal for registering test kits, creating accounts, retrieving diagnostic results, and managing personal health information and billing.
- Gaps in Care Solutions Population health testing program helping health plans close care gaps for HEDIS, Star, and MIPS metrics through member engagement, self-collection kits, and provider reporting.
Quantifiable outcome
- Processes hundreds of thousands of diagnostic tests on clinically and non-clinically collected samples every month
- +1 more outcomes
Companies that use Molecular Testing Labs
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles6 records
Molecular Testing Labs technology and API
TechnologyTechnology focussed No
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Molecular Testing Labs partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights6 records
Molecular Testing Labs competitors and assessment
Company assessmentBroad incumbents
- Quest Diagnostics: Largest US clinical reference laboratory offering a full menu of diagnostic testing across all 50 states. Directly comparable in CLIA-certified clinical chemistry, immunoassay, molecular, and esoteric testing, with much broader geographic reach and entrenched payor contracts.
- Labcorp: Major national clinical laboratory network with overlapping services in clinical chemistry, molecular diagnostics, pharmacogenetics, and women's health testing. Competes for the same healthcare provider, health plan, and clinical study customers as Molecular Testing Labs.
- Sonic Healthcare USA: International clinical laboratory operator with US operations providing full-service diagnostic testing to providers and health systems. Comparable in clinical lab service model and regulatory profile, with broader scale.
- Eurofins Clinical Diagnostics: Global clinical diagnostics provider including specialty esoteric testing, pharmacogenetics, and clinical trial support. Overlaps with MTL's clinical trial and pharmacogenomic testing services at larger scale.
Direct peers
- LetsGetChecked: Direct-to-consumer at-home diagnostics company offering self-collection test kits across hormone, STI, and wellness categories. Closely aligned business model and product set with MTL's CareNexa Wellness and self-collection capabilities.
- Everlywell: DTC at-home testing company offering panels for hormones, STIs, thyroid, and wellness through self-collected samples. Direct competitor in the consumer-facing self-collection segment where Molecular Testing Labs operates via CareNexa Wellness.
- ixlayer: API-first lab platform enabling telehealth and digital health companies to integrate at-home diagnostic testing. Highly comparable to MTL's API-driven white-label partner model serving digital health and retail health customers.
- BioReference Laboratories: Specialty clinical laboratory offering esoteric diagnostics, women's health, oncology, and infectious disease testing. Comparable mid-to-large independent lab serving providers and health plans with similar test menu breadth.
- myLAB Box: At-home STI and wellness testing company shipping self-collection kits directly to consumers. Closely comparable product offering to MTL's STI testing and wellness categories with similar DTC fulfillment model.
Others
- XIFIN: Health information technology vendor providing billing, LIS, and revenue cycle management to diagnostic laboratories. MTL's patient portal is hosted on XIFIN infrastructure, making XIFIN a strategic infrastructure partner rather than a direct competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Molecular Testing Labs social profiles
Digital presenceMolecular Testing Labs compliance and trust
Trust signalCompliance11 records
Molecular Testing Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Molecular Testing Labs leadership team
Management profileNumber of profiles
Profiles6 records
Molecular Testing Labs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Molecular Testing Labs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Molecular Testing Labs
What does Molecular Testing Labs do?
Molecular Testing Labs operates a CLIA-certified, CAP-accredited clinical diagnostic laboratory providing at-home specimen collection kits and molecular diagnostic testing for healthcare providers, health plans, digital health companies, public health organizations, and clinical study sponsors. The company offers a comprehensive test menu including STI screening, hormone panels, toxicology, pharmacogenetics, GLP-1 monitoring, wellness testing, and dried blood spot testing, supported by in-house kit construction, laboratory processing, and results delivery through a web-based LIS portal and a REST API.
Is Molecular Testing Labs a public or private company?
Molecular Testing Labs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Molecular Testing Labs founded?
Molecular Testing Labs was founded in 2011. It employs 101 to 250 people.
Where is Molecular Testing Labs based?
Molecular Testing Labs is headquartered in Vancouver, United States, in the North America region.
How does Molecular Testing Labs make money?
Three revenue lines are on record. Laboratory Diagnostic Testing Services are the primary driver. The others are healthcare Operations and Portal Services and population Health and Gaps in Care Programs.
Who are Molecular Testing Labs's main competitors?
Broad incumbents on record are Quest Diagnostics, Labcorp, Sonic Healthcare USA and Eurofins Clinical Diagnostics. Direct peers are LetsGetChecked, Everlywell, ixlayer, BioReference Laboratories and myLAB Box. XIFIN is listed as an others.
Does Molecular Testing Labs have an API?
Yes. REST API supporting lab order management (create, retrieve, update, delete orders), kit management (tracking, registration, bulk tracking), patient information retrieval and updates, and webhook notifications for order status changes. Authentication uses user token and practice/distributor ID. Supports multiple lines of business (SC, DNA, FIT, CGX, ID) with specific panel codes for different test types. Developer documentation is at go.moleculartestinglabs.com/support-api.
What industry is Molecular Testing Labs in?
Molecular Testing Labs's product category is Clinical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAFAMAB, Clinical Chemistry & Immunoassay Laboratories, with a secondary code of HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs. Its NAICS code is 621511 and its SIC code is 8071.